Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Heidelberg Pharma AG Director's Dealing 2024

Mar 26, 2024

201_dirs_2024-03-26_53771a07-2998-425c-bb57-9d9cc69d0a77.html

Director's Dealing

Open in viewer

Opens in your device viewer

News Details

Directors’ Dealings | 26 March 2024 16:11

Heidelberg Pharma AG: Dr. Georg F. Baur, buy

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

26.03.2024 / 16:10 CET/CEST

The issuer is solely responsible for the content of this announcement.

1. Details of the person discharging managerial responsibilities / person closely associated

a) Name

Title: Dr.
First name: Georg F.
Last name(s): Baur

2. Reason for the notification

a) Position / status

Position: Member of the administrative or supervisory body

b) Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name

Heidelberg Pharma AG

b) LEI

391200E09XYBYITR1W32

4. Details of the transaction(s)

a) Description of the financial instrument, type of instrument, identification code

Type: Share
ISIN: DE000A11QVV0

b) Nature of the transaction

Acquisition

c) Price(s) and volume(s)

Price(s) Volume(s)
3.0500 EUR 22,225.35 EUR
3.1000 EUR 22,710.60 EUR
3.1300 EUR 4,375.74 EUR
3.1400 EUR 12,525.46 EUR

d) Aggregated information

Price Aggregated volume
3.0919 EUR 61,837.1500 EUR

e) Date of the transaction

2024-03-25; UTC+1

f) Place of the transaction

Name: Frankfurt – Xetra
MIC: XETR

26.03.2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

Archive at www.eqs-news.com


Language: English
Company: Heidelberg Pharma AG
Gregor-Mendel-Str. 22
68526 Ladenburg
Germany
Internet: www.heidelberg-pharma.com
End of News EQS News Service

show this